Breaking News on Pharmaceutical Technology

Latest news headlines

Products

Suppliers

AMPAC sales jump 50% on return of antiviral revenues

09-Feb-2012 - AMPAC Fine Chemicals posted a 50 per cent jump in revenues after the return of sales from its antiviral business.

AMRI posts Q4 loss but expects contracting revs to grow in 2012

08-Feb-2012 - AMRI posted a Q4 loss on lower sales but predicts that contracting revenues and margins will increase in 2012 thanks to cost cutting measures and new contracts

Cambrex on takeover hunt amid pharma fine chem consolidation

08-Feb-2012 - Cambrex expects fine chemical consolidation to continue this year and is being “proactive” in its hunt for takeover targets.

CMO news roundup – Foster, Excella, Catalent and RohnerChem

02-Feb-2012 - A round-up of news in the contract manufacturing space, with developments at Foster Delivery Sciences, Excella, Catalent and RohnerChem.

FDA plans overseas inspections as GDUFA goes to Congress

16-Jan-2012 - The US FDA has sent its generic user fee recommendations to Congress ahead of a meeting to discuss the plan next month.

Collaboration needed to reverse supply chain “neglect”; expert

11-Jan-2012 - Greater collaboration between regulators, suppliers and manufacturers is needed to reverse decades of supply chain neglect, an expert said.

News in brief

Sanofi to make $170m cuts in operational costs

11-Jan-2012 - Sanofi announced it will cut $170m of its operational costs this year as it plans to ramp-up acquisitions spending to $2.6bn.

Xoma cuts manufacturing costs to ramp-up R&D

10-Jan-2012 - Xoma will further reduce its manufacturing capacity with plans to cut a third of its workforce.

USP publishes draft supply chain integrity chapter

09-Jan-2012 - The USP has published draft supply chain integrity guidance outlining steps to stop counterfeit or adulterated drugs reaching patients.

DSM signs MoU with AIBN on biologics commercialisation

20-Dec-2011 - DSM Biologics will work with the Australian Institute for Bioengineering and Nanotechnology (AIBN) on the commercialisation of development-stage biologics projects.

AMPAC posts Q4 loss as process improvement drags on profits

15-Dec-2011 - AMPAC posted a fourth quarter loss as process improvement difficulties offset rising demand for CNS and oncology ingredients.

EMA calls for Vistide recall over Ben Venue contamination fears

14-Dec-2011 - The EMA has recommended recalling a batch of Gilead’s Vistide manufactured by Ben Venue over particle contamination concerns.

Samsung and Quintiles' biosimilars JV teams with Biogen Idec

06-Dec-2011 - Samsung will set up a $300m biosimilars development JV with Massachusetts, US-based Biogen Idec, building on the partnership it forged with CRO Quintiles earlier this year.

US firm offering modular plant leases as alternative to CMOs

01-Dec-2011 - Biologics Modular is leasing its mobile production facilities to help clients make FDA regulated drugs without fixed plants.

FDA anti-adulteration efforts hindered by industry; GAO

28-Nov-2011 - Industry reluctance to share information on economic adulteration is hindering FDA efforts to tackle tainted ingredients, a GAO report found.

EMA recalling oncology drugs manufactured by Ben Venue

23-Nov-2011 - The EMA is recalling cancer drugs manufactured by CMO Ben Venue Laboratories after inspectors found quality shortcomings.

Shortages to worsen after Ben Venue suspends manufacture

21-Nov-2011 - Ben Venue Laboratories has voluntarily suspended manufacture at the Ohio plant linked to drug shortages.

Trust in drug source may blind wholesalers to counterfeits

15-Nov-2011 - Wholesalers’ trust in the quality of products from some countries could decrease vigilance and allow counterfeits to reach pharmacies, research found.

Pharma must improve existing methods to boost solubility as “quantum leap” unlikely

15-Nov-2011 - To boost solubility pharma must develop, refine and improve existing methods as a “quantum leap” in formulation is unlikely, Pharmaterials' CEO said.

Globalised supply chain drives EMA to rethink batch release

09-Nov-2011 - The EMA plans to update guidance on certification and batch release in response to globalisation of the pharma supply chain.

Pfizer & Bend collaborating on osteoarthritis nanoparticle drug delivery

03-Nov-2011 - Bend Research is developing a nanoparticle drug delivery system for treating osteoarthritis in a “close collaboration” with Pfizer.

Evonik to buy SurModics’ drug delivery assets and cGMP plant

02-Nov-2011 - SurModics is selling its drug delivery assets and cGMP manufacturing facility to Evonik for $30m (€22m) in cash.

Round-up of news & views from AAPS & CPhI 2011

31-Oct-2011 - In-PharmaTechnologist presents a roundup of news and views shared by exhibitors and attendees at AAPS and CPhI.

Canadian drug shortage plan fails to tackle problems; analyst

19-Oct-2011 - Canadian pharma manufacturers’ plan to stop drug shortages by sharing information fails to tackle underlying concerns, an analyst said.

Drug shortages drive demand surge & expansion at Akorn

10-Oct-2011 - Akorn is doubling capacity and hiring “as fast as [it] can” after drug shortages sent demand for its injectables soaring.

Sign up for your free newsletter